 Jasmina Redzic
Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Basigin | 3 | 2013 | 25 | 0.860 |
Why?
| | Metalloproteases | 1 | 2022 | 43 | 0.790 |
Why?
| | Immunoglobulin A | 1 | 2022 | 201 | 0.720 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 106 | 0.670 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 3 | 2024 | 25 | 0.550 |
Why?
| | Streptococcus pneumoniae | 3 | 2025 | 161 | 0.500 |
Why?
| | Models, Molecular | 12 | 2025 | 1488 | 0.490 |
Why?
| | RNA | 3 | 2023 | 877 | 0.490 |
Why?
| | Glioma | 2 | 2016 | 351 | 0.480 |
Why?
| | Neoplasm Proteins | 2 | 2016 | 417 | 0.470 |
Why?
| | Catalytic Domain | 6 | 2025 | 218 | 0.450 |
Why?
| | Mutation | 5 | 2025 | 3706 | 0.430 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 124 | 0.410 |
Why?
| | Extracellular Space | 1 | 2013 | 120 | 0.410 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 158 | 0.390 |
Why?
| | Serine Endopeptidases | 2 | 2025 | 120 | 0.390 |
Why?
| | Protein Conformation | 7 | 2025 | 861 | 0.370 |
Why?
| | Bacterial Proteins | 5 | 2025 | 838 | 0.360 |
Why?
| | Virulence Factors | 2 | 2022 | 157 | 0.360 |
Why?
| | Interleukin-6 | 1 | 2013 | 724 | 0.320 |
Why?
| | Evolution, Molecular | 2 | 2024 | 462 | 0.310 |
Why?
| | Bacteria | 3 | 2023 | 814 | 0.280 |
Why?
| | Interleukin-1 | 2 | 2024 | 956 | 0.280 |
Why?
| | Brain Neoplasms | 1 | 2016 | 1149 | 0.280 |
Why?
| | Protein Domains | 3 | 2025 | 254 | 0.260 |
Why?
| | Erythrocytes | 2 | 2021 | 673 | 0.250 |
Why?
| | Recombinant Proteins | 4 | 2025 | 1311 | 0.240 |
Why?
| | Serine Proteases | 1 | 2025 | 19 | 0.240 |
Why?
| | Cytochromes c | 1 | 2005 | 59 | 0.230 |
Why?
| | Trypsin | 1 | 2025 | 74 | 0.230 |
Why?
| | Immune Tolerance | 2 | 2019 | 356 | 0.230 |
Why?
| | Haemophilus | 1 | 2024 | 6 | 0.220 |
Why?
| | Cytokines | 3 | 2024 | 2022 | 0.220 |
Why?
| | Exosomes | 2 | 2015 | 97 | 0.220 |
Why?
| | Acinetobacter baumannii | 1 | 2023 | 18 | 0.210 |
Why?
| | Extracellular Vesicles | 2 | 2016 | 129 | 0.210 |
Why?
| | Haemophilus Infections | 1 | 2024 | 40 | 0.210 |
Why?
| | Haemophilus influenzae | 1 | 2024 | 64 | 0.210 |
Why?
| | Crystallography, X-Ray | 4 | 2025 | 438 | 0.210 |
Why?
| | Coenzymes | 2 | 2024 | 20 | 0.210 |
Why?
| | NAD | 1 | 2023 | 74 | 0.210 |
Why?
| | Interleukins | 2 | 2023 | 241 | 0.200 |
Why?
| | Streptococcus | 1 | 2022 | 26 | 0.200 |
Why?
| | Thermodynamics | 2 | 2020 | 407 | 0.190 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 170 | 0.190 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 22 | 0.190 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2005 | 383 | 0.180 |
Why?
| | Immune Evasion | 1 | 2021 | 54 | 0.180 |
Why?
| | Arthritis, Gouty | 1 | 2020 | 14 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 1 | 2005 | 530 | 0.170 |
Why?
| | Binding Sites | 2 | 2021 | 1251 | 0.170 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 66 | 0.170 |
Why?
| | Protease Inhibitors | 1 | 2020 | 107 | 0.170 |
Why?
| | Arthritis | 1 | 2020 | 90 | 0.160 |
Why?
| | Blood Donors | 1 | 2021 | 97 | 0.160 |
Why?
| | Neoplasms | 1 | 2014 | 2454 | 0.160 |
Why?
| | Oxidation-Reduction | 4 | 2024 | 1031 | 0.160 |
Why?
| | Prescription Drugs | 1 | 2021 | 112 | 0.160 |
Why?
| | Cyclophilin A | 2 | 2009 | 26 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2021 | 697 | 0.150 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 3185 | 0.150 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 593 | 0.150 |
Why?
| | Lymph | 2 | 2009 | 32 | 0.150 |
Why?
| | Humans | 23 | 2025 | 129847 | 0.150 |
Why?
| | Proteomics | 3 | 2016 | 1058 | 0.140 |
Why?
| | Proteins | 1 | 2023 | 944 | 0.140 |
Why?
| | Biomarkers, Tumor | 2 | 2014 | 1161 | 0.130 |
Why?
| | Mass Spectrometry | 3 | 2016 | 717 | 0.130 |
Why?
| | Shock, Hemorrhagic | 2 | 2009 | 165 | 0.130 |
Why?
| | Unfolded Protein Response | 1 | 2016 | 53 | 0.130 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2016 | 27 | 0.130 |
Why?
| | Amino Acid Sequence | 3 | 2025 | 2057 | 0.120 |
Why?
| | Huntington Disease | 1 | 2016 | 49 | 0.120 |
Why?
| | Protein Multimerization | 2 | 2019 | 179 | 0.120 |
Why?
| | Cell Line | 4 | 2019 | 2780 | 0.120 |
Why?
| | Alkynes | 1 | 2014 | 56 | 0.110 |
Why?
| | Azides | 1 | 2014 | 46 | 0.110 |
Why?
| | Click Chemistry | 1 | 2014 | 49 | 0.110 |
Why?
| | Allosteric Regulation | 2 | 2024 | 94 | 0.110 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2023 | 541 | 0.110 |
Why?
| | Animals | 11 | 2025 | 35409 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2013 | 76 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2019 | 804 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2015 | 546 | 0.100 |
Why?
| | Cell Communication | 1 | 2014 | 301 | 0.100 |
Why?
| | Mesentery | 2 | 2009 | 47 | 0.100 |
Why?
| | Protein Transport | 1 | 2013 | 429 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4077 | 0.090 |
Why?
| | Mice | 7 | 2025 | 16983 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 274 | 0.090 |
Why?
| | Protein Structure, Quaternary | 1 | 2011 | 121 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 926 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 836 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2011 | 379 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2748 | 0.080 |
Why?
| | Protein Binding | 3 | 2024 | 2123 | 0.080 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2008 | 35 | 0.070 |
Why?
| | HMGB1 Protein | 1 | 2008 | 49 | 0.070 |
Why?
| | S100 Proteins | 1 | 2008 | 35 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2020 | 4102 | 0.070 |
Why?
| | Catalysis | 2 | 2024 | 312 | 0.070 |
Why?
| | Gelsolin | 1 | 2007 | 9 | 0.070 |
Why?
| | Protein Folding | 1 | 2009 | 265 | 0.070 |
Why?
| | Aged | 3 | 2022 | 22107 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2008 | 212 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2015 | 1937 | 0.070 |
Why?
| | Interleukin-13 | 1 | 2008 | 147 | 0.070 |
Why?
| | Th2 Cells | 1 | 2008 | 171 | 0.070 |
Why?
| | Plant Proteins | 1 | 2007 | 89 | 0.070 |
Why?
| | Keratinocytes | 1 | 2008 | 244 | 0.070 |
Why?
| | Disease Progression | 1 | 2014 | 2628 | 0.060 |
Why?
| | Immunologic Factors | 1 | 2008 | 229 | 0.060 |
Why?
| | Autophagy | 1 | 2008 | 266 | 0.060 |
Why?
| | Arachis | 1 | 2007 | 109 | 0.060 |
Why?
| | Down-Regulation | 1 | 2008 | 631 | 0.060 |
Why?
| | Immunoglobulin E | 1 | 2007 | 330 | 0.060 |
Why?
| | Glioblastoma | 1 | 2008 | 322 | 0.060 |
Why?
| | Peanut Hypersensitivity | 1 | 2007 | 140 | 0.060 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 15 | 0.060 |
Why?
| | Glycoproteins | 1 | 2007 | 338 | 0.060 |
Why?
| | Protein Denaturation | 1 | 2005 | 74 | 0.060 |
Why?
| | Enzyme Stability | 1 | 2005 | 69 | 0.060 |
Why?
| | Allosteric Site | 1 | 2024 | 19 | 0.060 |
Why?
| | Hydrogen Bonding | 1 | 2005 | 149 | 0.060 |
Why?
| | Dermatitis, Atopic | 1 | 2008 | 319 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 363 | 0.050 |
Why?
| | Allergens | 1 | 2007 | 385 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2005 | 284 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 112 | 0.050 |
Why?
| | Heme | 1 | 2024 | 77 | 0.050 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2019 | 260 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 24 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 17 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 19 | 0.050 |
Why?
| | Deuterium | 1 | 2023 | 87 | 0.050 |
Why?
| | Hydrolases | 1 | 2023 | 56 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 40 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 104 | 0.050 |
Why?
| | Mutagenesis | 1 | 2023 | 179 | 0.050 |
Why?
| | Serine | 1 | 2023 | 137 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 69 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 373 | 0.050 |
Why?
| | Iron | 1 | 2024 | 285 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 51 | 0.050 |
Why?
| | Blood Banks | 1 | 2021 | 40 | 0.050 |
Why?
| | Arginine | 1 | 2023 | 262 | 0.050 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.050 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 42 | 0.040 |
Why?
| | Escherichia coli | 1 | 2025 | 766 | 0.040 |
Why?
| | Biocatalysis | 1 | 2020 | 68 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5468 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 201 | 0.040 |
Why?
| | Peritonitis | 1 | 2020 | 81 | 0.040 |
Why?
| | Hemolysis | 1 | 2021 | 199 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2020 | 371 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 605 | 0.040 |
Why?
| | Gene Expression | 1 | 2025 | 1465 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2020 | 178 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 139 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 578 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 314 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2021 | 182 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1092 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2019 | 93 | 0.040 |
Why?
| | Hemoglobins | 1 | 2021 | 339 | 0.040 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 16 | 0.040 |
Why?
| | NADP | 1 | 2018 | 47 | 0.040 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 113 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1264 | 0.040 |
Why?
| | Ligands | 1 | 2019 | 621 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2018 | 549 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2020 | 872 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 482 | 0.030 |
Why?
| | Huntingtin Protein | 1 | 2016 | 12 | 0.030 |
Why?
| | Neostriatum | 1 | 2016 | 33 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 441 | 0.030 |
Why?
| | Signal Transduction | 2 | 2022 | 4935 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 652 | 0.030 |
Why?
| | Protein Array Analysis | 1 | 2015 | 56 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 875 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 329 | 0.030 |
Why?
| | Cycloaddition Reaction | 1 | 2014 | 28 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 390 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2888 | 0.030 |
Why?
| | Copper | 1 | 2014 | 108 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1368 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 2014 | 207 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1724 | 0.030 |
Why?
| | Surface Properties | 1 | 2014 | 400 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2009 | 2403 | 0.030 |
Why?
| | Lung | 1 | 2024 | 3940 | 0.020 |
Why?
| | Rats | 2 | 2009 | 5487 | 0.020 |
Why?
| | Syndecan-1 | 1 | 2009 | 28 | 0.020 |
Why?
| | Male | 4 | 2021 | 63759 | 0.020 |
Why?
| | Static Electricity | 1 | 2009 | 117 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2008 | 65 | 0.020 |
Why?
| | beta-Defensins | 1 | 2008 | 20 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 342 | 0.020 |
Why?
| | Intermediate Filament Proteins | 1 | 2008 | 57 | 0.020 |
Why?
| | Point Mutation | 1 | 2009 | 224 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 2008 | 170 | 0.020 |
Why?
| | Protein Engineering | 1 | 2009 | 106 | 0.020 |
Why?
| | Middle Aged | 3 | 2021 | 31177 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2009 | 393 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 117 | 0.020 |
Why?
| | Basophil Degranulation Test | 1 | 2007 | 6 | 0.020 |
Why?
| | 2S Albumins, Plant | 1 | 2007 | 29 | 0.020 |
Why?
| | Basophils | 1 | 2007 | 73 | 0.020 |
Why?
| | Antigens, Plant | 1 | 2007 | 48 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 140 | 0.020 |
Why?
| | Adult | 3 | 2021 | 35634 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 844 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 2009 | 272 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 133 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 20451 | 0.020 |
Why?
| | Temperature | 1 | 2009 | 635 | 0.020 |
Why?
| | Mast Cells | 1 | 2007 | 142 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 338 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2008 | 650 | 0.020 |
Why?
| | Actins | 1 | 2007 | 410 | 0.010 |
Why?
| | Acute Disease | 1 | 2008 | 980 | 0.010 |
Why?
| | Plant Extracts | 1 | 2007 | 198 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 12467 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2016 | 0.010 |
Why?
| | Chronic Disease | 1 | 2008 | 1724 | 0.010 |
Why?
| | Calcium | 1 | 2008 | 1212 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 3384 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 1900 | 0.010 |
Why?
| | Female | 1 | 2021 | 68829 | 0.010 |
Why?
| | Child, Preschool | 1 | 2007 | 10522 | 0.010 |
Why?
| | Child | 1 | 2007 | 20962 | 0.000 |
Why?
|
|
Redzic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|